Pentixapharm

Pentixapharm is owned by Eckert & Ziegler. Eckert & Ziegler has a direct presence in 2 countries.

Eckert & Ziegler has 3 subsidiaries including Eckert & Ziegler Bebig, JPT Peptides Technologies and Pentixapharm.

They are in:

• Medical Equipment50%
• Healthcare25%
• Other25%

View the org chart displaying its 3 main executives

Most searched biographies at Pentixapharm

• Hakim Bouterfa, Chief Executive Officer
• Anna Steeger, Chief Financial Officer
• Jens Kaufmann, Managing Director, Manufacturing

Create your alert
to follow the executive moves at Pentixapharm.

Eckert & Ziegler has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by Pentixapharm

Social media about Pentixapharm

• Pentixapharm on Wikipedia, Google News & Yahoo Finance
• Pentixapharm on LinkedIn, Twitter & YouTube

Contact by email its executives including Hakim Bouterfa

Call Pentixapharm at +49 931 ...

View the org chart

Register to receive your alert

Report an error